FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912889372> ?p ?o ?g. }

• W2912889372 abstract "Objective: A recent, global, increase in the use of opioids including the prescribing, highly potent, fentanyl has been recorded. Due its current popularity and the potential lethal consequences of its intake, we aimed here at analysing the fentanyl misuse, abuse, dependence and withdrawal-related adverse drug reactions (ADRs) identified within the European Medicines Agency (EMA); the UK Yellow Card Scheme (YCS); and the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) databases. Methods: Descriptive analysis of both ADRs and related cases. Results: The analysis of fentanyl-related misuse, abuse, dependence and withdrawal cases reported during years 2004-2018 to the EMA; the YCS; and the FAERS showed increasing levels overtime; specifically, EMA-related data presented two peaks (e.g. in 2008 and 2015), whilst the FAERS dataset was characterised by a dramatic increase of the ADRs collected over the last 18 months, and particularly from 2016. Some 127,313 ADRs (referring to n=6,161 patients/single cases) related to fentanyl’s misuse/abuse/dependence/withdrawal issues were reported to EMA, with 14,287 being judged by the reporter as ‘suspect’. The most represented ADRs were: ‘drug dependence’ (76.87%); ‘intentional product misuse’ (13.06%); and ‘drug abuse’ (7.45%). Most cases involved adult males and the concomitant use of other prescribing/illicit drugs. A range of idiosyncratic (i.e. ingestion/injection of transdermal patches’ fentanyl) and very high-dosage intake cases were here identified. Significant numbers of cases required either a prolonged hospitalization (192/559=34.35%) or resulted in death (185/559=33.09%). Within the same time frame, YCS collected some 3,566 misuse/abuse/dependence/withdrawal ADRs, corresponding to 1,165 single patients/cases, with those most frequently reported being ‘withdrawal’; ‘intentional product misuse’; and ‘overdose’ ADRs. Finally, FAERS identified a total of 19,145 misuse/abuse/dependence/withdrawal-related cases, being ‘overdose’; withdrawal; and ‘drug use disorder/drug abuse/drug diversion’ the most represented ADRs (respectively 43.11%; 20.80; 20.29%). Conclusions: Fentanyl abuse may be considered a public health issue with significant implications for clinical practice. Spontaneous pharmacovigilance reporting systems should be considered for mapping new trends of drug abuse." @default.
• W2912889372 created "2019-02-21" @default.
• W2912889372 creator A5041705984 @default.
• W2912889372 creator A5058372793 @default.
• W2912889372 creator A5078706372 @default.
• W2912889372 creator A5080313345 @default.
• W2912889372 date "2019-02-01" @default.
• W2912889372 modified "2023-09-26" @default.
• W2912889372 title "Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems" @default.
• W2912889372 cites W1981513751 @default.
• W2912889372 cites W2035953191 @default.
• W2912889372 cites W2047434559 @default.
• W2912889372 cites W2066724335 @default.
• W2912889372 cites W2067495125 @default.
• W2912889372 cites W2115195514 @default.
• W2912889372 cites W2156580735 @default.
• W2912889372 cites W2215849244 @default.
• W2912889372 cites W2425287903 @default.
• W2912889372 cites W2489085829 @default.
• W2912889372 cites W2514932497 @default.
• W2912889372 cites W2530036819 @default.
• W2912889372 cites W2566961868 @default.
• W2912889372 cites W2568909074 @default.
• W2912889372 cites W2570063599 @default.
• W2912889372 cites W2585850592 @default.
• W2912889372 cites W2590306277 @default.
• W2912889372 cites W2592915937 @default.
• W2912889372 cites W2601256495 @default.
• W2912889372 cites W2622699130 @default.
• W2912889372 cites W2727271381 @default.
• W2912889372 cites W2730603686 @default.
• W2912889372 cites W2733037038 @default.
• W2912889372 cites W2738920882 @default.
• W2912889372 cites W2739913519 @default.
• W2912889372 cites W2746492870 @default.
• W2912889372 cites W2755596460 @default.
• W2912889372 cites W2762128566 @default.
• W2912889372 cites W2765815655 @default.
• W2912889372 cites W2767283662 @default.
• W2912889372 cites W2770217313 @default.
• W2912889372 cites W2785967556 @default.
• W2912889372 cites W2793506888 @default.
• W2912889372 cites W2794764561 @default.
• W2912889372 cites W2800878103 @default.
• W2912889372 cites W2801009482 @default.
• W2912889372 cites W2803157260 @default.
• W2912889372 cites W2805392782 @default.
• W2912889372 cites W2806504163 @default.
• W2912889372 cites W2809453729 @default.
• W2912889372 cites W2842331541 @default.
• W2912889372 cites W2884573343 @default.
• W2912889372 cites W2888831666 @default.
• W2912889372 cites W2891321860 @default.
• W2912889372 cites W2895091112 @default.
• W2912889372 cites W2904633754 @default.
• W2912889372 cites W2905700559 @default.
• W2912889372 doi "https://doi.org/10.3389/fphar.2019.00046" @default.
• W2912889372 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6367955" @default.
• W2912889372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30774595" @default.
• W2912889372 hasPublicationYear "2019" @default.
• W2912889372 type Work @default.
• W2912889372 sameAs 2912889372 @default.
• W2912889372 citedByCount "47" @default.
• W2912889372 countsByYear W29128893722019 @default.
• W2912889372 countsByYear W29128893722020 @default.
• W2912889372 countsByYear W29128893722021 @default.
• W2912889372 countsByYear W29128893722022 @default.
• W2912889372 countsByYear W29128893722023 @default.
• W2912889372 crossrefType "journal-article" @default.
• W2912889372 hasAuthorship W2912889372A5041705984 @default.
• W2912889372 hasAuthorship W2912889372A5058372793 @default.
• W2912889372 hasAuthorship W2912889372A5078706372 @default.
• W2912889372 hasAuthorship W2912889372A5080313345 @default.
• W2912889372 hasBestOaLocation W29128893721 @default.
• W2912889372 hasConcept C194828623 @default.
• W2912889372 hasConcept C197934379 @default.
• W2912889372 hasConcept C205679159 @default.
• W2912889372 hasConcept C2777105317 @default.
• W2912889372 hasConcept C2780035454 @default.
• W2912889372 hasConcept C2781072394 @default.
• W2912889372 hasConcept C71924100 @default.
• W2912889372 hasConcept C98274493 @default.
• W2912889372 hasConceptScore W2912889372C194828623 @default.
• W2912889372 hasConceptScore W2912889372C197934379 @default.
• W2912889372 hasConceptScore W2912889372C205679159 @default.
• W2912889372 hasConceptScore W2912889372C2777105317 @default.
• W2912889372 hasConceptScore W2912889372C2780035454 @default.
• W2912889372 hasConceptScore W2912889372C2781072394 @default.
• W2912889372 hasConceptScore W2912889372C71924100 @default.
• W2912889372 hasConceptScore W2912889372C98274493 @default.
• W2912889372 hasLocation W29128893721 @default.
• W2912889372 hasLocation W29128893722 @default.
• W2912889372 hasLocation W29128893723 @default.
• W2912889372 hasLocation W29128893724 @default.
• W2912889372 hasLocation W29128893725 @default.
• W2912889372 hasLocation W29128893726 @default.
• W2912889372 hasOpenAccess W2912889372 @default.
• W2912889372 hasPrimaryLocation W29128893721 @default.
• W2912889372 hasRelatedWork W1981226422 @default.
• W2912889372 hasRelatedWork W2001672425 @default.

• next